Drugs for West Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 47)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
PK 11195 |
|
Phase 4 |
|
85532-75-8 |
1345 |
Synonyms:
1-(2-Chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide
PK11195
PK-11195
|
PK-11195|PK11195
RP 52028
|
|
2 |
|
Ethanol |
Approved |
Phase 3 |
|
64-17-5 |
702 |
Synonyms:
[CH2Me(OH)]
[OEtH]
1-Hydroxyethane
ABLYSINOL
Absolute alcohol
Absolute ethanol
Absolute ethyl alcohol
Aethanol
Aethylalkohol
Alcare hand degermer
Alcohol
Alcohol (ethyl)
Alcohol anhydrous
Alcohol denatured
ALCOHOL DETERMINATION--ALCOHOL
Alcohol etilico
Alcohol etílico
Alcohol, absolute
Alcohol, Dehydrated
Alcohol, denatured
ALCOHOL, DILUTED
Alcohol, ethyl
Alcohol, grain
ALCOHOL, RUBBING
Alcohols
Alcool ethylique
Alcool éthylique
Alcool etilico
Algrain
Alkohol
Alkoholu etylowego
Aminoethanol
Anhydrol
Anhydrous alcohol
Anhydrous ethanol
Äthanol
Äthylalkohol
B3324
Beta-Aminoethanol
Beta-Aminoethyl Alcohol
Beta-Ethanolamine
Beta-Hydroxyethylamine
C2H5OH
Caswell No. 426
Colamine
Cologne spirit
Cologne spirits
Dehydrated alcohol
Dehydrated ethanol
Denatured alcohol
Denatured Alcohol Cd-10
Denatured Alcohol Cd-5
Denatured Alcohol Cd-5a
Denatured Alcohol Sd-1
Denatured Alcohol Sd-13a
Denatured Alcohol Sd-17
Denatured Alcohol Sd-23a
Denatured Alcohol Sd-28
Denatured Alcohol Sd-30
Denatured Alcohol Sd-39b
Denatured Alcohol Sd-39c
Denatured Alcohol Sd-3a
Denatured Alcohol Sd-40m
Denatured ethanol
Desinfektol el
Diluted alcohol
Distilled spirits
DRINKING ALCOHOL
E1510
Envision Conditioner Pdd 9020
ETA
Etanol
|
Etanolo
ETHANOL
éthanol
Ethanol 200 proof
Ethanol Absolute
Ethanol Absolute Bp
Ethanol Anhydrous
Ethanol Extra Pure
Ethanol solution
Ethanol, Silent Spirit
Ethicap
Ethyl alc
Ethyl alcohol
Ethyl Alcohol & Water, 10%
Ethyl Alcohol & Water, 20%
Ethyl Alcohol & Water, 30%
Ethyl Alcohol & Water, 40%
Ethyl Alcohol & Water, 5%
Ethyl Alcohol & Water, 50%
Ethyl Alcohol & Water, 60%
Ethyl Alcohol & Water, 70%
Ethyl Alcohol & Water, 80%
Ethyl Alcohol & Water, 95%
Ethyl Alcohol & Water, 96%
Ethyl alcohol anhydrous
Ethyl alcohol in alcoholic beverages
Ethyl alcohol usp
Ethyl Alcohol, Anhydrous
Ethyl Alcohol, Denatured
Ethyl hydrate
Ethyl hydroxide
Ethylol
Ethylolamine
EtOH
FEMA NO. 2419
Fermentation alcohol
Glycinol
Grain alcohol
Hinetoless
HSDB 531
Hydroxyethane
Infinity pure
Jaysol
Jaysol S
Lux
METHYLATED MINERAL
Methylated Spirit Mineralised
Methylcarbinol
Molasses alcohol
NCI-C03134
NSC-85228
PM-6193-200
Potato alcohol
Punctilious ethyl alcohol
Pyro
Reagent Alcohol
Silent spirit
SPIRIGEL
Spirit
Spirits OF wine
Spiritus vini
Spirt
SURG
Synasol
Tecsol
Tecsol C
Thanol
Thiofaco M-50
Undenatured ethanol
USAF EK-1597
VODKA
|
|
3 |
|
Strawberry |
Approved |
Phase 3 |
|
|
|
4 |
|
Tetracosactide |
Approved |
Phase 3 |
|
16960-16-0 |
16133802 16129617 |
Synonyms:
[<sup>125</sup>I]-ACTH(1-24)|[<sup>125</sup>I]-adrenocorticotropin(1-24)
ACTH (1-24)|adrenocorticotropic hormone (1-24)
ADRENOCORTICOTROPIC HORMONE 1-24
ADRENOCORTICOTROPIC HORMONE FRAGMENT 1-24 HUMAN, RAT
ALPHA(1-24)-CORTICOTROPHIN
ATCH (1-24)
BETA(1-24)-CORTICOTROPHIN
CORTICOTROPIN TETRACOSAPEPTIDE
CORTICOTROPIN-(1-24)
CORTICOTROPIN-(1-24) TETRACOSAPEPTIDE
CORTROSYN
Cortrosyn®
COSYNTROPIN
|
SERTYRSERMETGLUHISPHEARGTRPGLYLYSPROVALGLYLYSLYSARGARGPROVALLYSVALTYRPRO
SYN920
SYNACTHEN
SYNACTHEN DEPOT
SYSMEHFRWGKPVGKKRRPVKVYP
Tetracosactida
TETRACOSACTIDE
TETRACOSACTIDE ACETATE
TETRACOSACTRIN
VICOTROPE
Α1-24-CORTICOTROPHIN
Β1-24-CORTICOTROPHIN
|
|
5 |
|
Cannabidiol |
Approved, Investigational |
Phase 3 |
|
13956-29-1 |
521372 644019 |
Synonyms:
(−)-trans-2-p-mentha-1,8-dien-3-yl-5-pentylresorcinol
(−)-trans-cannabidiol
(1'R,2'R)-5'-methyl-4-pentyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydrobiphenyl-2,6-diol
BTX-1503
CANNABIDIOL
CBD
CBD|Epidiolex®|GWP42003-P|nabiximols (CBD + THC, fixed-dose oral spray)|Sativex® (CBD + THC, fixed-dose oral spray)
|
EPIDIOLEX
GWP42003
GWP-42003
GWP42003-P
GWP-42003-P
Δ1(2)-trans-cannabidiol
|
|
6 |
|
Folic acid |
Approved, Nutraceutical, Vet_approved |
Phase 3 |
|
59-30-3 |
6037 |
Synonyms:
(2S)-2-[(4-{[(2-AMINO-4-OXO-1,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}PHENYL)FORMAMIDO]PENTANEDIOIC ACID
(2S)-2-[[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]PHENYL]-OXO-METHYL]AMINO]PENTANEDIOIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]BENZOYL]AMINO]GLUTARIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]BENZOYL]AMINO]PENTANEDIOIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]PHENYL]CARBONYLAMINO]PENTANEDIOIC ACID
[<sup>3</sup>H]-folic acid
Acide folique
ácido fólico
Acidum folicum
ACIFOLIC
Apo-Folic
B03BB01
b9, Vitamin
BIO SCIENCE
CYTOFOL
DOSFOLAT B ACTIV
FOLACID
FOLACIN
FOLATE
FOLBAL
FOLCIDIN
FOLDINE
FOLETTES
FOLIAMIN
FOLIC ACID
Folic acid, (D)-isomer
Folic acid, (DL)-isomer
Folic acid, calcium salt (1:1)
Folic acid, monopotassium salt
Folic acid, monosodium salt
Folic acid, potassium salt
Folic acid, sodium salt
FOLICARE
FOLICET
FOLIPAC
|
FOLSAEURE
FOLSAN
FOLSAURE
Folsäure
FOLSAV
FOLVITE
Folvron
INCAFOLIC
LEXPEC
LIVER LACTOBACILLUS CASEI FACTOR
MILLAFOL
N-(4-{[(2-AMINO-4-OXO-3,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)-L-GLUTAMIC ACID
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamate
N-[(4-{[(2-AMINO-4-OXO-1,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}PHENYL)CARBONYL]-L-GLUTAMIC ACID
N-[4-[[(2-AMINO-3,4-DIHYDRO-4-OXO-6-PTERIDINYL)METHYL]AMINO]BENZOYL]-L-GLUTAMIC ACID
NATUR FLOW
N-Pteroyl-L-glutamate
N-PTEROYL-L-GLUTAMIC ACID
NSC-3073
PGA
PRECONCEIVE
PTEGLU
PTEROYLGLUTAMATE
PTEROYLGLUTAMIC ACID
PTEROYL-L-GLUTAMATE
PTEROYL-L-GLUTAMIC ACID
PTEROYL-L-MONOGLUTAMATE
PTEROYL-L-MONOGLUTAMIC ACID
PTEROYLMONOGLUTAMIC ACID
ROCHE
Vitamin B9
VITAMIN BC
VITAMIN BE
VITAMIN M
|
|
7 |
|
Pyridoxine |
Approved, Investigational, Nutraceutical, Vet_approved |
Phase 3 |
|
65-23-6 |
1054 |
Synonyms:
2-METHYL-3-HYDROXY-4,5-BIS(HYDROXYMETHYL)PYRIDINE
2-METHYL-3-HYDROXY-4,5-DI(HYDROXYMETHYL)PYRIDINE
2-METHYL-3-HYDROXY-4,5-DIHYDROXYMETHYLPYRIDINE
2-METHYL-4,5-BIS(HYDROXYMETHYL)-3-HYDROXYPYRIDINE
2-METHYL-4,5-DIMETHYLOL-PYRIDIN-3-OL
3-HYDROXY-2-PICOLINE-4,5-DIMETHANOL
3-HYDROXY-4,5-BIS(HYDROXYMETHYL)-2-METHYLPYRIDINE
3-HYDROXY-4,5-DIMETHYLOL-ALPHA-PICOLINE
3-Hydroxy-4,5-dimethylol-a-picoline
3-Hydroxy-4,5-dimethylol-α-picoline
4,5-BIS(HYDROXYMETHYL)-2-METHYL-PYRIDIN-3-OL
5-HYDROXY-6-METHYL-3,4-PYRIDINEDIMETHANOL
ADERMINE
GRAVIDOX
HEXA-BETALIN
|
HYDOXIN
M.V.I.-12
PIRIDOSSINA
PIRIDOXINA
PYRIDOXIN
PYRIDOXINE
PYRIDOXINE (VIT B6)
Pyridoxine hydrochloride
PYRIDOXINUM
PYRIDOXOL
Pyridoxol hydrochloride
PYRIDOXOLUM
Rodex
VITAMIN B6
|
|
8 |
|
Calcium, Dietary |
|
Phase 2, Phase 3 |
|
|
|
9 |
|
Soy Bean |
|
Phase 2, Phase 3 |
|
|
|
10 |
|
Vitamins |
|
Phase 3 |
|
|
|
11 |
|
Folate |
|
Phase 3 |
|
|
|
12 |
|
Vitamin B9 |
|
Phase 3 |
|
|
|
13 |
|
Vitamin B6 |
|
Phase 3 |
|
|
|
14 |
|
Trace Elements |
|
Phase 3 |
|
|
|
15 |
|
Vitamin B Complex |
|
Phase 3 |
|
|
|
16 |
|
Vitamin B 6 |
|
Phase 3 |
|
|
|
17 |
|
Micronutrients |
|
Phase 3 |
|
|
|
18 |
|
Pharmaceutical Solutions |
|
Phase 3 |
|
|
|
19 |
|
Calcium |
Nutraceutical |
Phase 2, Phase 3 |
|
7440-70-2 |
271 |
Synonyms:
Ca
Ca(2+)
Ca2+
Calcio
CALCIUM
Calcium element
|
CALCIUM ion
Calcium(2+)
Calcium, doubly charged positive ion
Calcium, elemental
Elemental calcium
Kalzium
|
|
20 |
|
Pyridoxal |
Experimental, Nutraceutical |
Phase 3 |
|
66-72-8 |
1050 |
Synonyms:
2-METHYL-3-HYDROXY-4-FORMYL-5-HYDROXYMETHYLPYRIDINE
3-HYDROXY-2-METHYL-5-METHYLOL-ISONICOTINALDEHYDE
3-HYDROXY-5-(HYDROXYMETHYL)-2-METHYL-4-PYRIDINECARBOXALDEHYDE
3-HYDROXY-5-(hydroxymethyl)-2-methylisonicotinaldehyde
3-HYDROXY-5-(HYDROXYMETHYL)-2-METHYL-PYRIDINE-4-CARBALDEHYDE
|
3-Hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxaldehyde
3-HYDROXY-5-(HYDROXYMETHYL)-2-METHYL-PYRIDINE-4-CARBOXALDEHYDE
PIRIDOXAL
PYRIDOXAL
Pyridoxaldehyde
|
|
21 |
|
Fenfluramine |
Approved, Illicit, Investigational, Withdrawn |
Phase 2 |
|
458-24-2 |
3337 |
Synonyms:
(+-)-Fenfluramine
(±)-fenfluramine
1-(m-Trifluoromethyl-phenyl)-2-ethylaminopropane
2-Ethylamino-1-(3-trifluoromethylphenyl)propane
3-(Trifluoromethyl)-N-ethyl-alpha-methylphenethylamine
3-(Trifluoromethyl)-N-ethyl-a-methylphenethylamine
3-(Trifluoromethyl)-N-ethyl-α-methylphenethylamine
Adifax®|Fintepla®|Pondimin®|ZX008
DL-Fenfluramine
Ethyl-[1-methyl-2-(3-trifluoromethyl-phenyl)-ethyl]-amine
Fenfluramina
Fenfluramine
Fenfluramine hydrochloride
Fenfluramine hydrochloride, (+-)-isomer
Fenfluramine hydrochloride, R isomer
|
Fenfluramine hydrochloride, R-isomer
Fenfluramine, (+-)-isomer
Fenfluramine, R isomer
Fenfluramine, R-isomer
Fenfluraminum
Hydrochloride, fenfluramine
Isomeride
N-Ethyl-1-(3-(trifluoromethyl)phenyl)propan-2-amine
N-Ethyl-alpha-methyl-3-trifluoromethylphenethylamine
N-Ethyl-a-methyl-3-trifluoromethylphenethylamine
N-Ethyl-α-methyl-3-trifluoromethylphenethylamine
Ponderax
Pondimin
Robins brand OF fenfluramine hydrochloride
|
|
22 |
|
Valproic acid |
Approved, Investigational |
Phase 2 |
|
99-66-1 |
3121 |
Synonyms:
(N-C3H7)2chcooh
(S)-2-Propyl-4-pentanoate
(S)-2-Propyl-4-pentanoic acid
2 Propylpentanoic acid
2-N-PROPYL-4-PENTENOIC ACID
2-N-Propyl-N-valerate
2-N-Propyl-N-valeric acid
2-Propylpentanoate
2-PROPYL-pentanoate
2-Propylpentanoic acid
2-PROPYL-pentanoIC ACID
2-Propylvalerate
2-Propylvaleric acid
44089
4-Heptanecarboxylate
4-Heptanecarboxylic acid
A-44090
A-44090|Depakote®|Epilim®|valproate sodium
Acetate, dipropyl
Acid, propylisopropylacetic
Acid, valproic
Acide valproique
acide valproïque
Acido valproico
ácido valproico
Acidum valproicum
Alti-valproic
Apo-divalproex
Apo-valproic
Apo-valproic syrup
Avugane
Baceca
Calcium valproate
Calcium, valproate
Convulex
Convulsofin
Delepsine
Depacon
Depakene
Depakin
Depakin chrono
Depakine
Depakine chrono
Depakote
Deproic
Di-N-propylacetate
Di-N-propylacetic acid
Di-N-propylessigsaeure
Di-N-propylessigsaure
Di-n-propylessigsäure
Dipropyl acetate
Dipropylacetate
Dipropylacetic acid
Divalproex
Divalproex sodium
DOM-divalproex
Dom-valproate
DOM-valproic
Dom-valproic acid
DOM-valproic acid e.c.
Dom-valproic acid syrup
DPA
Epiject i.v.
Epilex
Epilim
|
Epival
Epival er
Ergenyl
Gen-divalproex
Kyselina 2-propylvalerova
LEP321
Magnesium valproate
Med valproic
Mylproin
Myproate
Myproic acid
N-Dipropylacetic acid
N-DPA
Novo-divalproex
Novo-valproic
Novo-valproic - ecc
Novo-valproic soft gel cap
NSC-93819
Nu-valproic
PEAC
Penta-valproic
PHL-Valproate
PHL-Valproic acid
PHL-Valproic acid e.c.
PMS-Divalproex
PMS-Valproate
PMS-Valproic acid
PMS-Valproic acid e.c.
Propylisopropylacetic acid
Propylvaleric acid
Ratio-valproic - ecc
S(-)-4-En-valproate
S(-)-4-En-valproic acid
S-2-N-Propyl-4-pentenoate
S-2-N-Propyl-4-pentenoic acid
Sandoz valproic
Savicol
Semisodium valproate
Sodium hydrogen divalproate
Sodium valproate
Sodium, divalproex
Sodium, valproate
Sprinkle
STAVZOR
Valcote
Valparin
Valproate
Valproate calcium
Valproate semisodique [French]
Valproate semisodium
Valproate sodium
Valproate, calcium
Valproate, magnesium
Valproate, semisodium
Valproate, sodium
Valproato semisodico [Spanish]
Valproatum seminatricum [Latin]
VALPROIC ACID
Valproic acid usp
Valproic acid USP24
Valproic acid, sodium salt (2:1)
Valproinsaeure
Valproinsäure
VPA
Vupral
|
|
23 |
|
Carbamazepine |
Approved, Investigational |
Phase 2 |
|
298-46-4 |
2554 |
Synonyms:
5-Carbamoyl-5H-dibenz(b,F)azepine
5-Carbamoyl-5H-dibenz[b,F]azepine
5-Carbamoyl-5H-dibenzo(b,F)azepine
5-Carbamyl-5H-dibenzo(b,F)azepine
5H-Dibenz(b,F)azepine-5-carboxamide
Amizepine
Apo-Carbamazepine
ARBIL MR
Atretol
Biston
CALEPSIN
calepsin|Carnexiv®|Tegretol®
CARBAGEN SR
Carbamazepen
Carbamazepin
Carbamazepina
Carbamazepine
Carbamazépine
Carbamazepine acetate
Carbamazepine anhydrous
Carbamazepine dihydrate
Carbamazepine hydrochloride
Carbamazepine L-tartrate (4:1)
Carbamazepine phosphate
Carbamazepine sulfate (2:1)
Carbamazepinum
Carbamezepine
CARBATROL
Carbazepin
Carbazepine
Carbelan
Carnexiv
CBZ
EPIMAZ
|
EPIMAZ RET
Epitol
Equetro
Finlepsin
G-32883
GEIGY 32883
Karbamazepin
Lexin
Neurotol
Novo-Carbamaz
NSC-169864
Nu-Carbamazepine
Sirtal
SIRTAL RET
Stazepin
Stazepine
Taro-Carbamazepine
Taro-Carbamazepine Cr
TEG111
Tegretal
Tegretol
TEGRETOL CHEWTAB
Tegretol Chewtabs
Tegretol Cr
TEGRETOL PROLONGED RELEASE
TEGRETOL XR
TEGRETOL-XR
Telesmin
TERIL
TERIL RET
Timonil
TIMONIL 200 RET
TIMONIL 400 RET
|
|
24 |
|
Nitrazepam |
Approved |
Phase 2 |
|
146-22-5 |
4506 |
Synonyms:
1, 3-Dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one
1,3-Dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one
2,3-Dihydro-7-nitro-5-phenyl-1H-1,4-benzodiazepin-2-ON
2,3-Dihydro-7-nitro-5-phenyl-1H-1,4-benzodiazepin-2-one
7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one
7-Nitro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one
7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one
Aliud brand OF nitrazepam
Allphar brand OF nitrazepam
Alodorm
Alphapharma brand OF nitrazepam
Alpharma brand OF nitrazepam
Alter brand OF nitrazepam
Apodorm
Atempol
Benzalin
BENZALIN (TN)
Calsmin
CSP Brand OF nitrazepam
CT-Arzneimittel brand OF nitrazepam
DDSA brand OF nitrazepam
Dermatech brand OF nitrazepam
Desitin brand OF nitrazepam
Dormalon
Dormicum
Dormicum brand OF nitrazepam
Dormo-puren
Eatan
Eunoctin
Gerson
Hipnax
Hipsal
Ibrovek
ICN brand OF nitrazepam
Imadorm
Imeson
Imesont
Mogadon
N05CD02
N-Desmethylnimetazepam
Nelbon
Nelmat
Neozepam
Neuchlonic
|
Neuraxpharm brand OF nitrazepam
Nitrados
Nitrazadon
Nitrazep
NITRAZEPAM
Nitrazépam
Nitrazepam al
Nitrazepam neuraxpharm
Nitrazepam-neuraxpharm
Nitrazepamum
Nitrodiazepam
Norgine brand OF nitrazepam
Novanox
NSC-58775
Paxisyn
Pelson
Persopit
Pfleger brand OF nitrazepam
Protea brand OF nitrazepam
Radedorm
Relact
Remnos
Rhoxal nitrazepam
Rhoxal-nitrazepam
Rhoxalpharma brand OF nitrazepam
Ro 4-5360
Ro 5-3059
RO-45360
RO-4-5360
RO-53059
RO-5-3059
Scheurich brand OF nitrazepam
Serenade
Somitran
Somnite
Sonebon
Sonnolin
Surem
Taurus brand OF nitrazepam
Trazenin
Unisomnia
United drug brand OF nitrazepam
Wernigerode brand OF nitrazepam
|
|
25 |
|
Ganaxolone |
Approved, Investigational |
Phase 2 |
|
38398-32-2 |
22023730 6918305 |
Synonyms:
CCD-1042
CCD-1042|CCD1042|Ztalmy®
|
|
|
26 |
|
Serotonin Uptake Inhibitors |
|
Phase 2 |
|
|
|
27 |
|
Melanocyte-Stimulating Hormones |
|
Phase 2 |
|
|
|
28 |
|
Adrenocorticotropic Hormone |
|
Phase 2 |
|
|
|
29 |
|
beta-Endorphin |
|
Phase 2 |
|
|
|
Synonyms:
|
30 |
|
Sodium Channel Blockers |
|
Phase 2 |
|
|
|
31 |
|
Anti-Anxiety Agents |
|
Phase 2 |
|
|
|
32 |
|
Psychotropic Drugs |
|
Phase 2 |
|
|
|
33 |
|
Hypnotics and Sedatives |
|
Phase 2 |
|
|
|
34 |
|
Analgesics, Non-Narcotic |
|
Phase 2 |
|
|
|
35 |
|
Analgesics |
|
Phase 2 |
|
|
|
36 |
|
Diuretics, Potassium Sparing |
|
Phase 2 |
|
|
|
37 |
|
Neurosteroids |
|
Phase 2 |
|
|
|
38 |
|
GABA Modulators |
|
Phase 2 |
|
|
|
39 |
|
Serotonin |
Investigational, Nutraceutical |
Phase 2 |
|
50-67-9 |
5202 |
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5 Hydroxytryptamine
5-HT
5-HT|serotonin
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
5-Hydroxy-tryptamine
|
Antemovis
DS Substance
Enteramin
Enteramine
Hippophaine
Hydroxytryptamine
SEROTONIN
Serotonine
sérotonine
Thrombocytin
Thrombotonin
|
|
40 |
|
Lithium carbonate |
Approved |
|
|
554-13-2 |
|
Synonyms:
CAMCOLIT 250
CAMCOLIT 400
Carbonic acid, dilithium salt
CP-1546761
CP-15467-61
Dilithium carbonate
ESKALITH
ESKALITH CR
LISKONUM
|
LITHANE
Lithii carbonas
LITHIUM CARBONATE
LITHOBID
LITHONATE
LITHOTABS
NSC-16895
PHASAL
|
|
41 |
|
Sodium citrate |
Approved, Investigational |
|
|
68-04-2 |
23431961 |
Synonyms:
Anhydrous sodium citrate
Anhydrous trisodium citrate
Citric acid, trisodium salt
Natrii citras
Natrocitral
Sodium citrate anhydrous
Sodium citrate, anhydrous
|
Sodium citrate,anhydrous
Sodium citric acid
Trisodium 2-hydroxypropane-1,2,3-tricarboxylate
trisodium citrate anhydrous
Trisodium citrate, anhydrous
Trisodium-citrate
|
|
42 |
|
Citric acid |
Approved, Nutraceutical, Vet_approved |
|
|
77-92-9 |
311 |
Synonyms:
2-hydroxy-1,2,3-propanetricarboxyic acid
2-Hydroxy-1,2,3-propanetricarboxylate
2-Hydroxy-1,2,3-propanetricarboxylic acid
2-Hydroxytricarballylate
2-Hydroxytricarballylic acid
3-Carboxy-3-hydroxypentane-1,5-dioate
3-Carboxy-3-hydroxypentane-1,5-dioic acid
Acid monohydrate, citric
ácido cítrico
Acidum citricum
Aciletten
Anhydrous citrate
Anhydrous citric acid
beta-Hydroxytricarballylate
beta-Hydroxytricarballylic acid
Chemfill
Citraclean
Citrate
Citrate anhydrous
Citretten
CITRIC ACID
Citric acid anhydrous
CITRIC ACID HYDRATE
Citric acid monoglyceride
|
Citric acid monohydrate
Citric acid, anhydrous
Citric acid,anhydrous
Citro
Citronensaeure
Citronensäure
e 330
e330
E-330
FEMA NO. 2306
H3Cit
Hydrocerol a
INS NO.330
INS-330
Kyselina citronova
Monohydrate, citric acid
NSC-112226
NSC-30279
NSC-626579
Suby g
Uralyt u
UROLOGIC G
Uro-trainer
|
|
43 |
|
Endorphins |
|
|
|
|
|
44 |
|
Radiopharmaceuticals |
|
|
|
|
|
45 |
|
Fluorodeoxyglucose F18 |
|
|
|
|
|
46 |
|
Antidepressive Agents |
|
|
|
|
|
47 |
|
Citrate |
|
|
|
|
|
Interventional clinical trials:
(show all 39)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Neuroinflammation in Children With Infantile Spasms Measured With 11C-PK11195 Positron Emission Tomography: Response to ACTH |
Completed |
NCT02092883 |
Phase 4 |
ACTH |
2 |
An Open-Label, Single and Multiple Oral Dose Pharmacokinetic Study of Vigabatrin in Infants With Infantile Spasms |
Withdrawn |
NCT01413711 |
Phase 4 |
Vigabatrin |
3 |
Intravenous Methylprednisolone Versus High Dose Oral Prednisolone for the Treatment of Infantile Spasms: a Randomized Open-labelled Trial |
Unknown status |
NCT03876444 |
Phase 2, Phase 3 |
Intravenous Methylprednisolone;Oral Pednisolone |
4 |
Evaluation of the Modified Atkins Diet in Children With Epileptic Spasms Refractory to Hormonal Therapy: A Randomized Controlled Trial |
Unknown status |
NCT03807141 |
Phase 2, Phase 3 |
|
5 |
Randomized Trial of High Dose (4mg/kg) Versus Usual Dose (2mg/kg) Oral Prednisolone in the Treatment of Infantile Spasms. |
Completed |
NCT01575639 |
Phase 3 |
Oral prednisolone |
6 |
A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Cannabidiol (CBD; GWP42003-P) in Infants With Infantile Spasms Following an Initial Open-label Pilot Study |
Completed |
NCT02954887 |
Phase 3 |
GWP42003-P |
7 |
A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Cannabidiol (CBD; GWP42003-P) in Infants With Infantile Spasms Following an Initial Open-label Pilot Study |
Completed |
NCT02953548 |
Phase 3 |
GWP42003-P |
8 |
Efficacy and Tolerability of the Modified Atkins Diet in Patients With Infantile Spasms: a Pilot Study. |
Completed |
NCT01006811 |
Phase 2, Phase 3 |
|
9 |
Addition of Pyridoxine to Prednisolone in the Treatment of Infantile Spasms: A Randomized Controlled Trial |
Completed |
NCT01828437 |
Phase 3 |
Pyridoxine plus prednisolone;Prednisolone |
10 |
Comparison of Efficacy of Ketogenic Diet and ACTH Therapy Among Children With West Syndrome: A Pilot Randomized Control Trial |
Recruiting |
NCT05279118 |
Phase 2, Phase 3 |
ACTH |
11 |
A Phase 3, Randomized, Open-Label Study to Evaluate the Efficacy and Safety of AMZ002, Compared to Vigabatrin, in the Treatment of Infantile Spasms |
Not yet recruiting |
NCT05128344 |
Phase 3 |
AMZ002 injectable solution, 0.5mg/mL;Vigabatrin, oral |
12 |
A Novel Approach to Infantile Spasms: Combined Cosyntropin Injectable Suspension, 1 mg/mL and Vigabatrin Induction Therapy |
Suspended |
NCT03347526 |
Phase 3 |
Cosyntropin Injectable Suspension, 1 mg/mL;Cosyntropin Injectable Suspension 1 MG/ML + vigabatrin;Vigabatrin |
13 |
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of Cannabidiol Oral Solution as Adjunctive Therapy With Vigabatrin as Initial Therapy in Patients With Infantile Spasms |
Terminated |
NCT03421496 |
Phase 3 |
Cannabidiol Oral Solution;Placebo;Vigabatrin |
14 |
Prednisolone vs. Vigabatrin in the First-line Treatment of Infantile Spasms |
Withdrawn |
NCT02299115 |
Phase 3 |
Prednisolone;Vigabatrin |
15 |
Evaluation of the Modified Atkins Diet in Children With Infantile Spasms Refractory to Hormonal Therapy: a Randomized Controlled Trial |
Withdrawn |
NCT01549288 |
Phase 2, Phase 3 |
|
16 |
A Phase II Study of Fenfluramine for Treatment of Refractory Infantile Spasms |
Unknown status |
NCT04289467 |
Phase 2 |
Fenfluramine |
17 |
A Double-blind, Placebo-controlled, Dose-ranging Clinical Study to Evaluate the Safety, Tolerability, and Antiepileptic Activity of Ganaxolone in Treatment of Patients With Infantile Spasms |
Completed |
NCT00441896 |
Phase 2 |
Ganaxolone |
18 |
Phase II Randomized Study of Early Surgery Vs Multiple Sequential Antiepileptic Drug Therapy for Infantile Spasms Refractory to Standard Treatment |
Completed |
NCT00004758 |
Phase 2 |
carbamazepine;corticotropin;nitrazepam;pyridoxine;valproic acid |
19 |
An Open-label Clinical Study to Evaluate the Safety and Antiepileptic Activity of Ganaxolone in Treatment of Patients Diagnosed With Infantile Spasms. |
Terminated |
NCT00442104 |
Phase 2 |
Ganaxolone |
20 |
A Phase 2 Study to Assess the Efficacy and Safety of Cannabidiol Oral Solution for the Treatment of Refractory Infantile Spasms |
Terminated |
NCT02551731 |
Phase 2 |
Cannabidiol Oral Solution |
21 |
An Open-label Adaptive Study for the Assessment of Safety, Tolerability, Pharmacokinetics, and Efficacy of Multiple Doses of Radiprodil in Subjects With Drug-resistant Infantile Spasms |
Terminated |
NCT02829827 |
Phase 2 |
Radiprodil |
22 |
A Phase 2 Study to Assess the Safety, Tolerability, Exploratory Efficacy, and Pharmacokinetics of Orally Administered JBPOS0101 for Refractory Infantile Spasms Patients |
Terminated |
NCT03976076 |
Phase 2 |
JBPOS0101 |
23 |
A Phase I Open-Label Pilot Study to Investigate the Feasibility, Safety, Tolerability and Efficacy of Daily Administration of Tricaprilin in Subjects With Infantile Spasms |
Recruiting |
NCT04727970 |
Phase 1 |
Tricaprilin |
24 |
Early Treatment of Infants at High Risk of Developing West Syndrome With Low-dose Adrenocorticotropin Hormone (ACTH) |
Unknown status |
NCT01367964 |
|
adrenocorticotropin hormone |
25 |
Molecular Characterization of a Cohort of 73 Patients With Infantile Spasms Syndrome |
Completed |
NCT02885389 |
|
|
26 |
Short-term Ketogenic Diet as Compared With Conventional Long-term Trial in Refractory Infantile Spasms: A Randomized, Controlled Study |
Completed |
NCT00968136 |
|
|
27 |
Genetic Studies in Patients and Families With Infantile Spasms |
Completed |
NCT01723787 |
|
|
28 |
Acceptability Study of a New Paediatric Form of Vigabatrin in Infants and Children With Infantile Spasms or Pharmacoresistant Partial Epilepsy. Observational, Descriptive, Open-label, Multi-centric, Non-randomized Study |
Completed |
NCT02220114 |
|
Vigabatrin: Vigabatrin new ST formulation then Sabril® |
29 |
Epilepsy Phenome/Genome Project: A Phenotype/Genotype Analysis of Epilepsy |
Completed |
NCT00552045 |
|
|
30 |
Sabril Patient Registry |
Completed |
NCT01073579 |
|
Sabril® |
31 |
Natural History of Metabolic Abnormalities in Children With Epilepsy |
Completed |
NCT00001325 |
|
18 FDG |
32 |
Trial of Lithium Carbonate for Treatment of Osteoporosis Pseudoglioma Syndrome |
Completed |
NCT01108068 |
|
Lithium |
33 |
Efficacy of Vigabatrin With High Dose Prednisolone Combination Therapy Versus Vigabatrin Alone for Infantile Spasm: a Randomized Trial |
Recruiting |
NCT04302116 |
|
Combination therapy with vigabatrin and prednisolone;Vigabatrin Tablets |
34 |
Decreasing Parental Stress and Costs While Improving Overall Satisfaction of Caregivers of Infants With Infantile Spasms on ACTH Therapy Utilizing Innovative Telemedicine Technology: A Randomized Study |
Recruiting |
NCT04086992 |
|
|
35 |
Genetics of Epilepsy and Related Disorders |
Recruiting |
NCT01858285 |
|
|
36 |
The Effect of Spa and Massage on Babies on Colic Symptoms: A Randomised Controlled Trial |
Recruiting |
NCT05538936 |
|
|
37 |
Multicentre Real-life Follow-up Study of Rare Epileptic Syndromes in Children and Adolescents |
Not yet recruiting |
NCT05126914 |
|
|
38 |
A Phase 0 Non-interventional, Multi-center, Natural History Study in Pediatric Patients With Syntaxin Binding Protein 1 (STXBP1) Encephalopathy With Epilepsy |
Not yet recruiting |
NCT05462054 |
|
|
39 |
Trial of Growth Hormone for Osteoporosis Pseudoglioma Syndrome |
Withdrawn |
NCT01614171 |
|
|
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
|